It does not cause dependence, does not interact with GLP-1 receptor agonists, and works through an osmotic mechanism rather than stimulating the colon directly
OB/GYN Approved for Quality and Safety
Despite being discovered first, it received less clinical attention for decades because early research suggested that GIP signaling was impaired in type 2 diabetes, making it seem like an unlikely therapeutic target
Used individually, each compound targets a distinct receptor pathway in the hypothalamic-pituitary axis
As a new form of programmed cell death, ferroptosis was first prescribed in 2012 [1]
People with high insulin resistance (ie, people with obesity), young age at dysglycaemia, abnormal 1 h glucose concentrations (86 mmol/L) despite normal 2 hr glucose concentrations on 75 g oral glucose tolerance test, and low C-peptide are at higher risk for progressing to stage 3 (fast progressor, stage 2b) than those diagnosed with dysglycaemia after age 65 years (slow progressor, stage 2a)